Dustin Garrett Gibson

Dustin Garrett Gibson

Auto-generated profile, based on publicly available information

Dustin Garrett Gibson

Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Cell
Verified
Journal Article
Closed access
GNGreg Neely
Greg Neely
AHAndreas Hess
Andreas Hess
MCMichael Costigan
Michael Costigan
AKAlex C. Keene
Alex C. Keene
SGSpyros Goulas
Spyros Goulas
JPJosef M Penninger
Josef M Penninger

8 March 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FRFrank Reimann
Frank Reimann
JCJames J. Cox
James J. Cox
IBInna Belfer
Inna Belfer
LDLuda Diatchenko
Luda Diatchenko
DZDmitri V. Zaykin
Dmitri V. Zaykin
GWGeoff Christopher Woods
Geoff Christopher Woods
The gene SCN9A is responsible for three human pain disorders. Nonsense mutations cause a complete absence of pain, whereas activating mutations cause severe episodic pain in paroxysmal extreme pain disorder and primary erythermalgia. This led us to investigate whether single nucleotide polymorphisms (SNPs) in SCN9A were associated with differing pain perception in the general population. We first genotyped 27 SCN9A SNPs in 578 individuals with a radiographic diagnosis of osteoarthritis and a pain score assessment. A significant association was found between pain score and SNP rs6746030; the rarer A allele was associated with increased pain scores compared to the commoner G allele ( P = 0.016). This SNP was then further genotyped in 195 pain-assessed people with sciatica, 100 amputees with phantom pain, 179 individuals after lumbar discectomy, and 205 individuals with pancreatitis. The combined P value for increased A allele pain was 0.0001 in the five cohorts tested (1277 people in total). The two alleles of the SNP rs6746030 alter the coding sequence of the sodium channel Nav1.7. Each was separately transfected into HEK293 cells and electrophysiologically assessed by patch-clamping. The two alleles showed a difference in the voltage-dependent slow inactivation ( P = 0.042) where the A allele would be predicted to increase Nav1.7 activity. Finally, we genotyped 186 healthy females characterized by their responses to a diverse set of noxious stimuli. The A allele of rs6746030 was associated with an altered pain threshold and the effect mediated through C-fiber activation. We conclude that individuals experience differing amounts of pain, per nociceptive stimulus, on the basis of their SCN9A rs6746030 genotype.

1 April 2017 in The Lancet Global Health
Verified
Journal Article
Open access
DGDustin G Gibson
Dustin G Gibson
BOBenard Ochieng
Benard Ochieng
EKE Wangeci Kagucia
E Wangeci Kagucia
JWJoyce Were
Joyce Were
KHKyla Hayford
Kyla Hayford
DFDaniel R Feikin
Daniel R Feikin
As mobile phone access continues to expand globally, opportunities exist to leverage these technologies to support demand for immunisation services and improve vaccine coverage. We aimed to assess whether short message service (SMS) reminders and monetary incentives can improve immunisation uptake in Kenya. In this cluster-randomised controlled trial, villages were randomly and evenly allocated to four groups: control, SMS only, SMS plus a 75 Kenya Shilling (KES) incentive, and SMS plus 200 KES (85 KES = USD$1). Caregivers were eligible if they had a child younger than 5 weeks who had not yet received a first dose of pentavalent vaccine. Participants in the intervention groups received SMS reminders before scheduled pentavalent and measles immunisation visits. Participants in incentive groups, additionally, received money if their child was timely immunised (immunisation within 2 weeks of the due date). Caregivers and interviewers were not masked. The proportion of fully immunised children (receiving BCG, three doses of polio vaccine, three doses of pentavalent vaccine, and measles vaccine) by 12 months of age constituted the primary outcome and was analysed with log-binomial regression and General Estimating Equations to account for correlation within clusters. This trial is registered with ClinicalTrials.gov, number NCT01878435. Between Oct 14, 2013, and Oct 17, 2014, we enrolled 2018 caregivers and their infants from 152 villages into the following four groups: control (n=489), SMS only (n=476), SMS plus 75 KES (n=562), and SMS plus 200 KES (n=491). Overall, 1375 (86%) of 1600 children who were successfully followed up achieved the primary outcome, full immunisation by 12 months of age (296 [82%] of 360 control participants, 332 [86%] of 388 SMS only participants, 383 [86%] of 446 SMS plus 75 KES participants, and 364 [90%] of 406 SMS plus 200 KES participants). Children in the SMS plus 200 KES group were significantly more likely to achieve full immunisation at 12 months of age (relative risk 1·09, 95% CI 1·02-1·16, p=0·014) than children in the control group. In a setting with high baseline immunisation coverage levels, SMS reminders coupled with incentives significantly improved immunisation coverage and timeliness. Given that global immunisation coverage levels have stagnated around 85%, the use of incentives might be one option to reach the remaining 15%. Bill & Melinda Gates Foundation.

1 November 2011 in The Journal of Pain
Verified
Journal Article
Closed access
SSShad B Smith
Shad B Smith
DMDylan W. Maixner
Dylan W. Maixner
JGJoel D. Greenspan
Joel D. Greenspan
RDRonald Dubner
Ronald Dubner
RFRoger B Fillingim
Roger B Fillingim
LDLuda Diatchenko
Luda Diatchenko

1 January 2013 in Vaccine
Verified
Journal Article
Closed access
HWHotenzia Wakadha
Hotenzia Wakadha
SCSubhash Chandir
Subhash Chandir
VWVincent Omondi Were
Vincent Omondi Were
ARAlan Rubin
Alan Rubin
DODavid Obor
David Obor
DFDaniel R. Feikin
Daniel R. Feikin

5 May 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DGDustin G Gibson
Dustin G Gibson
APAmanda Pereira
Amanda Pereira
BFBrooke Farrenkopf
Brooke Farrenkopf
ALAlain B Labrique
Alain B Labrique
GPGeorge W Pariyo
George W Pariyo
AHAdnan A Hyder
Adnan A Hyder
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet